Quantification of the Synergistic Inhibitory Effects of an Oncolytic Herpes Virus Plus Paclitaxel on Anaplastic Thyroid Cancer Cells
Conventional synergy theory explains the inhibitory effects of drug combinations at specific times. Determining the magnitude of inhibition is crucial for exploring the synergy effect. In the results of previous studies, the Chou–Talalay multiple drug effect analysis demonstrated that the combinatio...
Saved in:
| Main Authors: | Anna Park, Jong Hyuk Byun, Il Hyo Jung, Shingo Iwami, Kwang Su Kim |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-01-01
|
| Series: | Complexity |
| Online Access: | http://dx.doi.org/10.1155/cplx/3899849 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Response to neoadjuvant paclitaxel predicts survival in anaplastic thyroid carcinoma
by: Haruhiko Yamazaki, et al.
Published: (2023-02-01) -
Cytotoxic effect of celastrol alone or in combination with paclitaxel on anaplastic thyroid carcinoma cells
by: Si Hyoung Kim, et al.
Published: (2017-04-01) -
Lenvatinib plus pembrolizumab compared to carboplatin plus paclitaxel for carboplatin and paclitaxel pretreated, recurrent, or advanced endometrial cancer
by: Shao-Jing Wang, et al.
Published: (2025-03-01) -
Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumors
by: Gabriel Capellá, et al.
Published: (2022-03-01) -
Advances in the Drug Development and Quality Evaluation Principles of Oncolytic Herpes Simplex Virus
by: Basma Eid Abdullah Ghorab, et al.
Published: (2025-04-01)